Re-imagining CRISPR Technology for Use with Primary Immune Cells: New Insights for Cell-Based Immunotherapy Research
In this webinar, Dr. Shifrut presents a novel pooled CRISPR screening technology with the potential to prioritize novel targets for cancer immunotherapy drug development and to improve the design of genetically reprogrammed cell-based therapies.
Publish Date:
August 28, 2019
Related Multimedia
-
CAR T Cell Manufacturing Workflow: Isolation, Activation and Expansion
Publish Date: April 17, 2017
